Lifeline Biotechnologies Inc (LLBO)

[confirm]

Rob Royea Twitter
#DailyNews, June 22, 2018 (GMT+8)
iFLYTEK, in cooperation with Cyrcadia Asia to integrate core AI technology of intelligent voice into breast cancer prevention.
#WeChat #JD #iFLYTEK #CyrcadiaAisa #Google #Facebook #Microsoft #AI #MachineLearning #DeepLearning

“WORLDS LARGEST DATABASE”
iFlytek ‘s medical department was established in 2016 and is led by Dr. Tao Xiaodong, a senior technical expert from Philips and GE Healthcare. Dr. Tao Xiaodong, General Manager of iFlytek Smart Healthcare, has extensive experience in medical imaging and computer-aided diagnostics. The iFlytek has also made rapid progress in medical + artificial intelligence in the past two years. In November 2017, the company’s “Little Doctor” artificial intelligence robot successfully passed the national medical examination, and the Chinese doctor qualification examination scored 456 points, 96 points higher than the qualified standard. In addition, iFlytek currently deploys artificial intelligence services in more than 50 hospitals in Anhui Province to provide GPs with diagnostic, therapeutic and interpretation support for medical images including breast imaging.
With the completion of this financing, iFlytek will also work with Cyrcadia Asia to explore how to integrate Cyrcadia’s technology into iFlytek ‘s medical products in China. At the same time, Dr. Tao Xiaodong also joined the board of directors of Cyrcadia Asia.
Dr. Tao Xiaodong commented on this investment: “We are very pleased to play a leading role in Cyrcadia’s technology development and market launch. iFlytek has already practiced the power of artificial intelligence in the medical field, and Cyrcadia’s technology uses metabolic changes to detect Diseases, which can overcome and compensate for the many shortcomings of current imaging technology and manual interpretation. We are also pleased with Cyrcadia’s consumer wearable device technology, which provides women with the convenience and possibility to monitor their health in real time. With the growth of the group, it is likely to become the world’s largest database of breast health and breast cancer, and we hope that in the near future we will be able to make significant contributions to the research, prevention and treatment of this disease.”

“WE ARE EXCITED. RAISED $3.6 BILLION AND “”ACCELERATING”” INVESTMENTS”
"We are excited to play a leading role in the development and launch of Cyrcadia’s technology. iFlytek is already harnessing the power of AI in healthcare, but Cyrcadia’s technology, by using metabolic change to detect disease, can leapfrog many of the current drawbacks of imaging and human interpretation. We are also excited by the promise of Cyrcadia’s technology as a consumer wearable device, providing real-time monitoring for women at their own convenience," said iFlytek Health’s CEO Tao Xiaodong.
In addition to the investment, iFlytek and Cyrcadia Asia will be exploring how to integrate Cyrcadia’s technology into iFlytek’s healthcare offering in China.
iFlytek is best known for its voice-recognition technology, but the company is also accelerating investment in other AI applications, including healthcare and smart vehicle. In May, it announced plans to raise up to RMB3.6 billion (US$567 million) through private placement to expand its artificial intelligent investments.

“SHORTCOMING IN CURRENT IMAGING TECHNOLOGIES”
Iflytek is the biggest artificial intelligence firm listed in China, and began its foray into healthcare in 2016. Dr. Tao Xiaodong, an expert with medical imaging and computer-aided diagnosis experience at Philips Healthcare and GE Healthcare, founded the department and is set to become a director at Cyrcadia Asia.
The patches detect cancer by observing metabolic changes, Tao said. This makes up for shortcoming in current imaging technologies and human interpretation, and provides a convenient way for women to monitor their health. The increasing number of users could make the service the largest breast health incidence database, and provide information for research into cancer preventions and treatments, he added.
Iflytek took quickly to the healthcare sector, and in November 2017 its AI robot Xiaoyi passed the national medical exam, the test required to qualify as a doctor in China. The bot scored 456 points, 96 more than the pass mark. The company now runs AI services at more than 50 hospitals in its home province an Anhui, helping doctors to diagnose and treat diseases and interpret medical images. 

“500 MILLION PEOPLE”
Business Impact
Why 500 Million People in China Are Talking to This AI
iFlytek’s voice recognition technology is everywhere in China, and that’s what’s making it smarter every day.
by Yiting Sun September 14, 2017
In China, over 500 million people use iFlytek Input to overcome obstacles in communication such as the one Xu faces. Some also use it to send text messages through voice commands while driving, or to communicate with a speaker of another Chinese dialect. The app was developed by iFlytek, a Chinese AI company that applies deep learning in a range of fields such as speech recognition, natural-language processing, machine translation, and data mining (see “50 Smartest Companies 2017”).

“FAR AHEAD OF THE USA”
China counts on AI to find a cure for its ailing health care system
TECH NEWS
Monday, 2 Jul 2018 ?12:00 PM MYT
Read more at http://www.scmp.com/tech/china-tech/article/2153144/china-counts-ai-find-cure-its-ailing-health-ca
“China is already far ahead of the US in AI enabled diagnosis,” said Ni Hao, health care chief executive at Yitu Technology, a Shanghai-based AI start-up that specialises in facial recognition systems. There are two reasons for that, according to Ni. First, the shortage of doctors in the US is not as dire as in China, and second, US AI-start ups may not be able to afford a large medical team because American doctors earn between US$250,000.

“INITIAL
DIAGNOSIS”
iFlytek boosts use of AI in healthcare sector
2017-12-04 09:24 China Daily Editor: Wang Zihao-
Doctors there are well served by a smart, well-qualified assistant. 'She' records patients' symptoms, reviews computerized tomography scan images and makes initial diagnosis. Only, she is not human but a robot that runs on artificial intelligence.
Developed by iFlytek Co Ltd, a leading Chinese AI company, the robot aced the written test of China's national medical licensing examination-it is a test that aspiring doctors need to pass-in November, thus becoming the first device in the world to achieve the feat. It received 456 marks, 96 more than the minimum required to qualify.
In November, iFlytek was chosen by the central government as one of the four tech heavyweights to build the national AI open innovation platform by leveraging voice computing technologies.

Conclusion:
Elementary my dear Watson, the iT Bra has brilliantly timed it’s arrival in Asia, we must act fast and buy shares
of LLBO before this monster iFlytek gobbles them up. Brilliant Holmes, I was wondering just how much longer
you were going to smell this one out.

Well fellow investors we all like to talk about are investments made with are hard earned money, but this is one
I have finally reached a confidence level of enormous gratitude and realistically see a high probability of being
aquiered $$$. iFlytec Co. Is all over this, and ripe with Billions in investment money. ???